Skip To Main Content
Lu Chen on Muck Rack

Lu Chen

Sunnyvale
As seen in: Forbes, AIChE Journal, British Journal of Cancer, Color Research & Application, Nature, Wiley, Wiley Online Library, arXiv, British Pharmacological Society, Oxford Academic and
Experimenting with life

Get in touch with Lu

Contact Lu, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Influence of Pressurized Pipeline Leakage and Oil Pool Fires on Parallel Natural Gas Pipelines

|
By Guoxi He, Lu Chen, Yuanjie Huang, Xuechuang Zhao
| ascelibrary.org
Get full access to this article View all available purchase options and get full access to this article. Data Availability Statement Some or all data, models, or code that support the findings of this study are available from the corresponding author upon reasonable request. Acknowledgments This research was supported by the National Natural Science Foundation of China (Grant Nos. 52202403 and 52174062). Author Contributions Guoxi He: Funding acquisition; Methodology.
Open in Who Shared Issue with article?

Distinct Suppression of Prednisone on Endometrial Immune Cells in Women With Reproductive Failure

|
By Lu Chen, Xiaoyan Chen, qianhan Xu, Wen-Jui Yang
| Wiley Online Library Verified
1 Introduction Endometrial immune cells undergo dynamic adaptations in preparation for various biological events during production. Specifically, during the window of implantation (WOI) and early pregnancy, there is a robust increase in uterine natural killer (NK), followed by macrophages [1].
Open in Who Shared Issue with article?

Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant - Nature Biomedical Engineering

|
By Weiqi Hong, Jiong Li, Xiangyu Pan, Hongbo Hu, Haohao Dong, Jian Lei, Lu Chen, Xikun Zhou, Wei Qing Wang, Xiangrong Song, Shuaiyao Lu, Qiangming Sun, Guangwen Lu, Youchun Wang, Weimin Li
| Nature Verified
Abstract Mucosal immunity provides efficient protection against upper-airway infections, limiting viral shedding and transmission. However, currently, no nasal spray COVID-19 vaccines are approved by WHO for global use. Here we develop a two-component intranasal vaccine that combines an adenovirus vector expressing the spike protein of the XBB.1.5 variant (Ad5XBB.1.5) with a self-assembled trimeric recombinant protein derived from the receptor binding domain (RBDXBB.1.5-HR).
Open in Who Shared Issue with article?
See all 764 licensed articles (783 Total)